Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases
- PMID: 25041865
- PMCID: PMC4297589
- DOI: 10.1016/j.cgh.2014.07.018
Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases
Abstract
Background & aims: Crohn's disease and ulcerative colitis are associated with an increased risk of colorectal cancer (CRC). Surveillance colonoscopy is recommended at 2- to 3-year intervals beginning 8 years after diagnosis of inflammatory bowel disease (IBD). However, there have been no reports of whether colonoscopy examination reduces the risk for CRC in patients with IBD.
Methods: In a retrospective study, we analyzed data from 6823 patients with IBD (2764 with a recent colonoscopy, 4059 without a recent colonoscopy) seen and followed up for at least 3 years at 2 tertiary referral hospitals in Boston, Massachusetts. The primary outcome was diagnosis of CRC. We examined the proportion of patients undergoing a colonoscopy within 36 months before a diagnosis of CRC or at the end of the follow-up period, excluding colonoscopies performed within 6 months before a diagnosis of CRC, to avoid inclusion of prevalent cancers. Multivariate logistic regression was performed, adjusting for plausible confounders.
Results: A total of 154 patients developed CRC. The incidence of CRC among patients without a recent colonoscopy (2.7%) was significantly higher than among patients with a recent colonoscopy (1.6%) (odds ratio [OR], 0.56; 95% confidence interval [CI], 0.39-0.80). This difference persisted in multivariate analysis (OR, 0.65; 95% CI, 0.45-0.93) and was robust when adjusted for a range of assumptions in sensitivity analyses. Among patients with CRC, a colonoscopy within 6 to 36 months before diagnosis was associated with a reduced mortality rate (OR, 0.34; 95% CI, 0.12-0.95).
Conclusions: Recent colonoscopy (within 36 months) is associated with a reduced incidence of CRC in patients with IBD, and lower mortality rates in those diagnosed with CRC.
Keywords: CD; Colon Cancer; Early Detection; Risk Factor; Screening; UC.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
Comment in
-
Can Colonoscopy Reduce the Risk of Colon Cancer and Mortality in Patients With Inflammatory Bowel Disease?Clin Gastroenterol Hepatol. 2015 Sep;13(9):1702-3. doi: 10.1016/j.cgh.2015.02.032. Epub 2015 Feb 25. Clin Gastroenterol Hepatol. 2015. PMID: 25725440 No abstract available.
-
Reply: To PMID 25041865.Clin Gastroenterol Hepatol. 2015 Sep;13(9):1703-4. doi: 10.1016/j.cgh.2015.05.009. Epub 2015 May 10. Clin Gastroenterol Hepatol. 2015. PMID: 25970734 No abstract available.
References
-
- Eaden J. Review article: colorectal carcinoma and inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20(Suppl 4):24–30. - PubMed
-
- Herrinton LJ, Liu L, Levin TR, et al. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology. 2012;143:382–389. - PubMed
-
- Jess T, Loftus EV, Jr, Velayos FS, et al. Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Inflamm Bowel Dis. 2006;12:669–676. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
